Panax ginseng Cambium Stem Cell Composition for Hepatitis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating hepatitis, particularly chronic hepatitis B, are inadequate as they often lead to viral mutations and drug resistance, with no effective cure or method to directly treat the disease, and existing treatments have significant side effects.
Innovation Solution
A composition containing a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng, which is undifferentiated, morphologically characterized by multiple vacuoles, and has inhibitory effects on hepatitis virus proliferation and immune-enhancing properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antiviral drugs are continuously administered to prevent hepatitis from developing into serious liver disease, then the disease progression is inhibited, but viral mutations occur that induce resistance to the drugs
Solution Approach 1:
The patent uses plant stem cell lines from Panax ginseng cambium as an intermediary substance to treat hepatitis. Instead of directly using antiviral drugs that cause resistance, the stem cell extract acts as a mediator that enhances immune response and inhibits viral replication through natural compounds, thereby avoiding the harmful effect of viral mutation and drug resistance while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent changes the therapeutic parameter from synthetic antiviral drugs to natural plant stem cell extracts. This parameter change involves using undifferentiated plant cells with specific characteristics (homogeneous cell line, multiple vacuoles, specific morphology) that produce bioactive compounds capable of inhibiting hepatitis virus without inducing resistance, thus resolving the contradiction between therapeutic effect and drug resistance.
2Reliability
If interferon-α is used to treat hepatitis, then some therapeutic effect is achieved, but patients with vertical transmission show resistance and the effect is not continuous
Solution Approach 1:
The patent replaces interferon-α with plant stem cell extracts as an intermediary therapeutic agent. The stem cell lines from Panax ginseng contain natural compounds that can enhance immune function and inhibit viral replication without the resistance issues associated with interferon-α, particularly in vertically transmitted cases, thereby providing continuous and adaptable therapeutic effect.
Solution Approach 2:
The patent utilizes the self-service capability of plant stem cells to produce bioactive compounds that naturally inhibit hepatitis virus. The undifferentiated stem cell lines continuously generate protective substances that adapt to different patient conditions, including vertical transmission cases, providing sustained therapeutic effect without developing resistance.
3Reliability
If a homogeneous cell line derived from cambium of Panax ginseng is used as active ingredient, then viral proliferation is inhibited and immune response is enhanced, but the complexity of producing and characterizing the cell line increases
Solution Approach 1:
The patent extracts the essential therapeutic components from the complex plant stem cell system by using the entire cell line, extract, lysate, or culture as the active ingredient. This extraction approach simplifies the production process compared to isolating and characterizing individual compounds, while maintaining the reliable inhibitory effect on hepatitis virus through the combined action of multiple bioactive substances present in the stem cell preparations.
Data Source
AI summary
The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.